Skip to main content
Premium Trial:

Request an Annual Quote

University of Minnesota Genomics Center Gets $750K CDC Contract to Sequence SARS-CoV-2

NEW YORK — The University of Minnesota Genomics Center said on Tuesday that it has been awarded a nearly $750,000 contract from the US Centers for Disease Control and Prevention to sequence 6,000 SARS-CoV-2 samples to aid in virus surveillance.

The center will work with the Minnesota Department of Health to sequence the samples, which will primarily come from Minnesota but may include ones from surrounding Upper Midwest states, over a one-year period. The reported data will only contain genomic information from the virus, not the infected individual.

"This new resource not only will keep the momentum of the COVID-19 variant surveillance within Minnesota, but also boost the entire US central region states' SARS-CoV-2 whole-genome sequencing effort," Sean Wang, a sequencing and bioinformatics supervisor at the MDH, said in a statement. "More importantly, the research component will help University of Minnesota researchers further understand COVID-19 host-pathogen interactions through sequencing."

UMGC said that the CDC contract will build on the sequencing of over 3,000 viral genomes it performed for the MDH in recent weeks.

The Scan

Renewed Gain-of-Function Worries

The New York Times writes that the pandemic is renewing concerns about gain-of-function research.

Who's Getting the Patents?

A trio of researchers has analyzed gender trends in biomedical patents issued between 1976 and 2010 in the US, New Scientist reports.

Other Uses

CBS Sunday Morning looks at how mRNA vaccine technology could be applied beyond SARS-CoV-2.

PLOS Papers Present Analysis of Cervicovaginal Microbiome, Glycosylation in Model Archaea, More

In PLOS this week: functional potential of the cervicovaginal microbiome, glycosylation patterns in model archaea, and more.